Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development

Research output: Contribution to journalReview article

139 Citations (Scopus)
1093 Downloads (Pure)

Abstract

Transdermal drug delivery offers a number of advantages for the patient, due not only its non-invasive and convenient nature, but also factors such as avoidance of first pass metabolism and prevention of gastrointestinal degradation. It has been demonstrated that microneedle arrays can increase the number of compounds amenable to transdermal delivery by penetrating the skin's protective barrier, the stratum corneum, and creating a pathway for drug permeation to the dermal tissue below. Microneedles have been extensively investigated in recent decades for drug and vaccine delivery as well as minimally invasive patient monitoring/diagnosis. This review focuses on a range of critically important aspects of microneedle technology, namely their material composition, manufacturing techniques, methods of evaluation and commercial translation to the clinic for patient benefit and economic return. Microneedle research and development is finally now at the stage where commercialisation is a realistic possibility. However, progress is still required in the areas of scaled-up manufacture and regulatory approval.
Original languageEnglish
Pages (from-to)1 - 32
Number of pages32
JournalMaterials Science and Engineering: R: Reports
Volume104
Early online date13 Apr 2016
DOIs
Publication statusPublished - Jun 2016

Fingerprint

Materials science
Patient monitoring
Vaccines
Drug delivery
Metabolism
Permeation
Pharmaceutical Preparations
Skin
Tissue
Degradation
Economics
Chemical analysis
Drug Delivery Systems

Keywords

  • Microfabrication

Cite this

@article{82c7a42cc378401bb8793dfeae156dc9,
title = "Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development",
abstract = "Transdermal drug delivery offers a number of advantages for the patient, due not only its non-invasive and convenient nature, but also factors such as avoidance of first pass metabolism and prevention of gastrointestinal degradation. It has been demonstrated that microneedle arrays can increase the number of compounds amenable to transdermal delivery by penetrating the skin's protective barrier, the stratum corneum, and creating a pathway for drug permeation to the dermal tissue below. Microneedles have been extensively investigated in recent decades for drug and vaccine delivery as well as minimally invasive patient monitoring/diagnosis. This review focuses on a range of critically important aspects of microneedle technology, namely their material composition, manufacturing techniques, methods of evaluation and commercial translation to the clinic for patient benefit and economic return. Microneedle research and development is finally now at the stage where commercialisation is a realistic possibility. However, progress is still required in the areas of scaled-up manufacture and regulatory approval.",
keywords = "Microfabrication",
author = "Eneko Larra{\~n}eta and Lutton, {Rebecca E.M.} and Woolfson, {A. David} and Donnelly, {Ryan F.}",
year = "2016",
month = "6",
doi = "10.1016/j.mser.2016.03.001",
language = "English",
volume = "104",
pages = "1 -- 32",
journal = "Materials Science and Engineering: R: Reports",
issn = "0927-796X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Microneedle arrays as transdermal and intradermal drug delivery systems: Materials science, manufacture and commercial development

AU - Larrañeta, Eneko

AU - Lutton, Rebecca E.M.

AU - Woolfson, A. David

AU - Donnelly, Ryan F.

PY - 2016/6

Y1 - 2016/6

N2 - Transdermal drug delivery offers a number of advantages for the patient, due not only its non-invasive and convenient nature, but also factors such as avoidance of first pass metabolism and prevention of gastrointestinal degradation. It has been demonstrated that microneedle arrays can increase the number of compounds amenable to transdermal delivery by penetrating the skin's protective barrier, the stratum corneum, and creating a pathway for drug permeation to the dermal tissue below. Microneedles have been extensively investigated in recent decades for drug and vaccine delivery as well as minimally invasive patient monitoring/diagnosis. This review focuses on a range of critically important aspects of microneedle technology, namely their material composition, manufacturing techniques, methods of evaluation and commercial translation to the clinic for patient benefit and economic return. Microneedle research and development is finally now at the stage where commercialisation is a realistic possibility. However, progress is still required in the areas of scaled-up manufacture and regulatory approval.

AB - Transdermal drug delivery offers a number of advantages for the patient, due not only its non-invasive and convenient nature, but also factors such as avoidance of first pass metabolism and prevention of gastrointestinal degradation. It has been demonstrated that microneedle arrays can increase the number of compounds amenable to transdermal delivery by penetrating the skin's protective barrier, the stratum corneum, and creating a pathway for drug permeation to the dermal tissue below. Microneedles have been extensively investigated in recent decades for drug and vaccine delivery as well as minimally invasive patient monitoring/diagnosis. This review focuses on a range of critically important aspects of microneedle technology, namely their material composition, manufacturing techniques, methods of evaluation and commercial translation to the clinic for patient benefit and economic return. Microneedle research and development is finally now at the stage where commercialisation is a realistic possibility. However, progress is still required in the areas of scaled-up manufacture and regulatory approval.

KW - Microfabrication

U2 - 10.1016/j.mser.2016.03.001

DO - 10.1016/j.mser.2016.03.001

M3 - Review article

VL - 104

SP - 1

EP - 32

JO - Materials Science and Engineering: R: Reports

JF - Materials Science and Engineering: R: Reports

SN - 0927-796X

ER -